Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys ; volume:8 ; number:1 ; day:10 ; month:11 ; year:2023 ; pages:1-12 ; date:12.2023
npj vaccines ; 8, Heft 1 (10.11.2023), 1-12, 12.2023
- Urheber
-
Boopathy, Archana V.
Sharma, Bhawna
Nekkalapudi, Anurag
Wimmer, Raphaela
Gamez-Guerrero, Maria
Suthram, Silpa
Truong, Hoa
Lee, Johnny
Li, Jiani
Martin, Ross
Blair, Wade
Geleziunas, Romas
Orlinger, Klaus
Ahmadi-Erber, Sarah
Lauterbach, Henning
Makadzange, Tariro
Falkard, Brie
Schmidt, Sarah
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-023-00768-x
- URN
-
urn:nbn:de:101:1-2024012914525595597962
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boopathy, Archana V.
- Sharma, Bhawna
- Nekkalapudi, Anurag
- Wimmer, Raphaela
- Gamez-Guerrero, Maria
- Suthram, Silpa
- Truong, Hoa
- Lee, Johnny
- Li, Jiani
- Martin, Ross
- Blair, Wade
- Geleziunas, Romas
- Orlinger, Klaus
- Ahmadi-Erber, Sarah
- Lauterbach, Henning
- Makadzange, Tariro
- Falkard, Brie
- Schmidt, Sarah
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
SiV
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model
Güterverzeichnisse Si-V
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
SiV
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model
Güterverzeichnisse Si-V
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
SiV
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model